• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与依匹单抗相关的垂体炎导致的低钠血症。

Hyponatremia associated with Ipilimumab-induced hypophysitis.

机构信息

Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, White Building Room 502, Boston, MA 02114, USA.

出版信息

Med Oncol. 2012 Mar;29(1):374-7. doi: 10.1007/s12032-010-9794-7. Epub 2011 Jan 25.

DOI:10.1007/s12032-010-9794-7
PMID:21264545
Abstract

A 75-year-old woman with a history of stage IV metastatic melanoma underwent treatment with the CTLA-4 blocking agent Ipilimumab. She presented 2 months after initiating treatment with a severe headache. Laboratories were consistent with severe hyponatremia. MRI of the brain revealed enlargement of the pituitary gland, enhancement of the infundibulum, and an enhancing, centrally necrotic foci in the anterior pituitary. Based on the clinical and radiographic findings, she was diagnosed with treatment-related syndrome of inappropriate antidiuretic hormone secretion (SIADH). Effective treatment consisted of fluid restriction, hyperosmolar therapy, and steroids.

摘要

一位 75 岁的女性,患有 IV 期转移性黑色素瘤,接受 CTLA-4 阻断剂 Ipilimumab 治疗。她在开始治疗后 2 个月出现严重头痛。实验室检查符合严重低钠血症。脑 MRI 显示垂体增大,漏斗增强,以及前垂体中央坏死灶增强。根据临床和影像学发现,她被诊断为与治疗相关的抗利尿激素分泌不当综合征(SIADH)。有效的治疗方法包括限制液体摄入、高渗治疗和类固醇治疗。

相似文献

1
Hyponatremia associated with Ipilimumab-induced hypophysitis.与依匹单抗相关的垂体炎导致的低钠血症。
Med Oncol. 2012 Mar;29(1):374-7. doi: 10.1007/s12032-010-9794-7. Epub 2011 Jan 25.
2
Systemic high-dose corticosteroid treatment does not improve the outcome of ipilimumab-related hypophysitis: a retrospective cohort study.全身大剂量皮质类固醇治疗不能改善与伊匹单抗相关的垂体炎的预后:一项回顾性队列研究。
Clin Cancer Res. 2015 Feb 15;21(4):749-55. doi: 10.1158/1078-0432.CCR-14-2353. Epub 2014 Dec 23.
3
Pituitary enlargement following ipilimumab without long term endocrine dysfunction.使用依匹单抗后出现垂体增大,但无长期内分泌功能障碍。
Curr Probl Cancer. 2021 Dec;45(6):100710. doi: 10.1016/j.currproblcancer.2021.100710. Epub 2021 Feb 10.
4
Ipilimumab-induced hypophysitis: MR imaging findings.依匹单抗相关性垂体炎:磁共振成像表现。
AJNR Am J Neuroradiol. 2009 Oct;30(9):1751-3. doi: 10.3174/ajnr.A1623. Epub 2009 May 27.
5
Ipilimumab-induced hypophysitis and uveitis in a patient with metastatic melanoma and a history of ipilimumab-induced skin rash.在一名转移性黑色素瘤患者中,使用伊匹单抗(ipilimumab)后出现垂体炎和葡萄膜炎,该患者有伊匹单抗(ipilimumab)引起的皮疹病史。
J Natl Compr Canc Netw. 2014 Aug;12(8):1077-81. doi: 10.6004/jnccn.2014.0105.
6
Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma.Ipilimumab 诱导的垂体炎的长期随访,这是黑色素瘤抗 CTLA-4 抗体的常见不良事件。
Eur J Endocrinol. 2015 Feb;172(2):195-204. doi: 10.1530/EJE-14-0845. Epub 2014 Nov 21.
7
Detection of early onset of hypophysitis by (18)F-FDG PET-CT in a patient with advanced stage melanoma treated with ipilimumab.应用(18)F-FDG PET-CT 检测伊匹单抗治疗晚期黑色素瘤患者的垂体炎早期发病。
Clin Nucl Med. 2013 Apr;38(4):e182-4. doi: 10.1097/RLU.0b013e3182639765.
8
The syndrome of inappropriate secretion of antidiuretic hormone in the maxillofacial trauma patient.颌面部创伤患者抗利尿激素分泌异常综合征
Oral Surg Oral Med Oral Pathol. 1985 May;59(5):460-2. doi: 10.1016/0030-4220(85)90082-9.
9
Symptomatic hyponatremia as a presenting sign of hypothalamic-pituitary disease: a syndrome of inappropriate secretion of antidiuretic hormone (SIADH)-like glucocorticosteroid responsive condition.症状性低钠血症作为下丘脑 - 垂体疾病的首发症状:一种类似抗利尿激素不适当分泌综合征(SIADH)的糖皮质激素反应性疾病。
J Endocrinol Invest. 2005 Feb;28(2):151-6. doi: 10.1007/BF03345358.
10
[Ipilimumab-induced hypophysitis].[伊匹单抗诱发的垂体炎]
Rofo. 2013 Mar;185(3):268-9. doi: 10.1055/s-0032-1325515. Epub 2012 Nov 15.

引用本文的文献

1
An Update on Advances in Hypopituitarism: Etiology, Diagnosis, and Current Management.垂体功能减退症的进展更新:病因、诊断及当前治疗
J Clin Med. 2024 Oct 16;13(20):6161. doi: 10.3390/jcm13206161.
2
Pre-treatment of hyponatremia as a biomarker for poor immune prognosis in advanced or metastatic gastric cancer: A retrospective case analysis.低钠血症预处理作为晚期或转移性胃癌免疫预后不良的生物标志物:回顾性病例分析。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2414546. doi: 10.1080/21645515.2024.2414546. Epub 2024 Oct 16.
3
Immune checkpoint inhibitor related nephrotoxicity: Advances in clinicopathologic features, noninvasive approaches, and therapeutic strategy and rechallenge.

本文引用的文献

1
Improved survival with ipilimumab in patients with metastatic melanoma.Ipilimumab 改善转移性黑色素瘤患者的生存。
N Engl J Med. 2010 Aug 19;363(8):711-23. doi: 10.1056/NEJMoa1003466. Epub 2010 Jun 5.
2
Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trial.术前 CTLA-4 阻断:术前临床试验中耐受性和免疫监测。
Clin Cancer Res. 2010 May 15;16(10):2861-71. doi: 10.1158/1078-0432.CCR-10-0569. Epub 2010 May 11.
3
The syndrome of inappropriate antidiuretic hormone: current and future management options.
免疫检查点抑制剂相关肾毒性:临床病理特征、非侵入性方法、治疗策略及再次挑战方面的进展
Front Nephrol. 2022 Oct 19;2:1017921. doi: 10.3389/fneph.2022.1017921. eCollection 2022.
4
Immunotherapy in oncology and the kidneys: a clinical review of the evaluation and management of kidney immune-related adverse events.肿瘤学与肾脏领域的免疫疗法:肾脏免疫相关不良事件评估与管理的临床综述
Clin Kidney J. 2023 Jan 28;16(6):939-951. doi: 10.1093/ckj/sfad014. eCollection 2023 Jun.
5
Lymphocytic Hypophysitis in a Patient With Suspected Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH).疑似抗利尿激素分泌不当综合征(SIADH)患者的淋巴细胞性垂体炎
Cureus. 2022 Oct 11;14(10):e30178. doi: 10.7759/cureus.30178. eCollection 2022 Oct.
6
The side effects of immune checkpoint inhibitor therapy on the endocrine system.免疫检查点抑制剂治疗对内分泌系统的副作用。
Indian J Med Res. 2021 Apr;154(4):559-570. doi: 10.4103/ijmr.IJMR_313_19.
7
Metabolic and Nutritional Disorders Following the Administration of Immune Checkpoint Inhibitors: A Pharmacovigilance Study.免疫检查点抑制剂治疗后的代谢和营养障碍:一项药物警戒研究。
Front Endocrinol (Lausanne). 2022 Jan 25;12:809063. doi: 10.3389/fendo.2021.809063. eCollection 2021.
8
Organ-specific Adverse Events of Immune Checkpoint Inhibitor Therapy, with Special Reference to Endocrinopathies.免疫检查点抑制剂治疗的器官特异性不良事件,特别提及内分泌病
touchREV Endocrinol. 2021 Apr;17(1):21-32. doi: 10.17925/EE.2021.17.1.21. Epub 2021 Apr 28.
9
Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges.肾功能不全患者的肝细胞癌:病理生理学、预后和治疗挑战。
World J Gastroenterol. 2021 Jul 14;27(26):4104-4142. doi: 10.3748/wjg.v27.i26.4104.
10
Management of endocrine immune-related adverse events of immune checkpoint inhibitors: an updated review.免疫检查点抑制剂内分泌免疫相关不良事件的管理:最新综述
Endocr Connect. 2020 Oct;9(10):R207-R228. doi: 10.1530/EC-20-0342.
抗利尿激素分泌不当综合征:当前和未来的治疗选择。
Eur J Endocrinol. 2010 Jun;162 Suppl 1:S13-8. doi: 10.1530/EJE-09-1057. Epub 2010 Feb 17.
4
Anti-CTLA-4 antibody therapy associated autoimmune hypophysitis: serious immune related adverse events across a spectrum of cancer subtypes.抗 CTLA-4 抗体治疗相关自身免疫性垂体炎:多种癌症亚型的严重免疫相关不良事件。
Pituitary. 2010;13(1):29-38. doi: 10.1007/s11102-009-0193-z. Epub 2009 Jul 29.
5
Lymphocytic infundibulo-neurohypophysitis and infundibulo-panhypophysitis regarded as lymphocytic hypophysitis variant.淋巴细胞性漏斗神经垂体炎和漏斗全垂体炎被视为淋巴细胞性垂体炎的变异型。
Brain Tumor Pathol. 2008;25(2):59-66. doi: 10.1007/s10014-008-0234-8. Epub 2008 Nov 6.
6
Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis.伊匹单抗(抗细胞毒性T淋巴细胞相关抗原4抗体)可使转移性肾细胞癌消退,同时伴有肠炎和垂体炎。
J Immunother. 2007 Nov-Dec;30(8):825-30. doi: 10.1097/CJI.0b013e318156e47e.
7
Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade.与接受细胞毒性T淋巴细胞相关抗原4阻断治疗的转移性黑色素瘤患者临床反应相关的预后因素。
Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6681-8. doi: 10.1158/1078-0432.CCR-07-0187. Epub 2007 Nov 2.
8
Clinical practice. The syndrome of inappropriate antidiuresis.临床实践。抗利尿激素分泌失调综合征
N Engl J Med. 2007 May 17;356(20):2064-72. doi: 10.1056/NEJMcp066837.
9
Characteristics and mortality of severe hyponatraemia--a hospital-based study.严重低钠血症的特征与死亡率——一项基于医院的研究。
Clin Endocrinol (Oxf). 2006 Aug;65(2):246-9. doi: 10.1111/j.1365-2265.2006.02583.x.
10
Incidence and prevalence of hyponatremia.低钠血症的发病率和患病率。
Am J Med. 2006 Jul;119(7 Suppl 1):S30-5. doi: 10.1016/j.amjmed.2006.05.005.